VUMC News and Communications

U.S. Health and Human Services Secretary Alex Azar visited VUMC Tuesday, Sept. 15, to learn more about the Medical Center’s ongoing Moderna COVID-19 vaccine trial and the convalescent plasma trial. Both studies are funded through the National Institutes of Health’s Operation Warp Speed. In the photo above, Azar and VUMC’s Jennifer Pietenpol, PhD, speak with reporters during a press conference following Azar’s visit.

HHS Secretary Azar visits VUMC

U.S. Health and Human Services Secretary Alex Azar visited VUMC Tuesday, Sept. 15, to learn more about the Medical Center’s ongoing Moderna COVID-19 vaccine trial and the convalescent plasma trial.

HIV prevention medication not being prescribed routinely: study

Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

New predictors of prostate cancer risk

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.

Roumie to direct Master of Public Health program

Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health.

Newsweek recognizes Vanderbilt Stallworth Rehabilitation Hospital as among America’s best

Newsweek has recognized the Vanderbilt Stallworth Rehabilitation Hospital and its partner Encompass Health as among America’s Best Physical Rehabilitation Centers for 2020.

Possible key to COVID-19 infectivity

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.

1 120 121 122 123 124 416